Genetic basis for individual variations in pain perception and the development of a chronic pain condition

Luda Diatchenko, Gary D. Slade, Andrea G. Nackley, Konakporn Bhalang, Asgeir Sigurdsson, Inna Belfer, David Goldman, Ke Xu, Svetlana A. Shabalina, Dmitry Shagin, Mitchell B. Max, Sergei S. Makarov, William Maixner

Research output: Contribution to journalArticle

Abstract

Pain sensitivity varies substantially among humans. A significant part of the human population develops chronic pain conditions that are characterized by heightened pain sensitivity. We identified three genetic variants (haplotypes) of the gene encoding catecholamine-O-methyltransferase (COMT) that we designated as low pain sensitivity (LPS), average pain sensitivity (APS) and high pain sensitivity (HPS). We show that these haplotypes encompass 96% of the human population, and five combinations of these haplotypes are strongly associated (P = 0.0004) with variation in the sensitivity to experimental pain. The presence of even a single LPS haplotype diminishes, by as much as 2.3 times, the risk of developing myogenous temporomandibular joint disorder (TMD), a common musculoskeletal pain condition. The LPS haplotype produces much higher levels of COMT enzymatic activity when compared with the APS or HPS haplotypes. Inhibition of COMT in the rat results in a profound increase in pain sensitivity. Thus, COMT activity substantially influences pain sensitivity, and the three major haplotypes determine COMT activity in humans that inversely correlates with pain sensitivity and the risk of developing TMD.

Original languageEnglish (US)
Pages (from-to)135-143
Number of pages9
JournalHuman Molecular Genetics
Volume14
Issue number1
DOIs
StatePublished - Jan 1 2005

Fingerprint

Pain Perception
Chronic Pain
Pain
Haplotypes
Methyltransferases
Catecholamines
Temporomandibular Joint Disorders
Musculoskeletal Pain
Human Activities
Population

ASJC Scopus subject areas

  • Genetics

Cite this

Genetic basis for individual variations in pain perception and the development of a chronic pain condition. / Diatchenko, Luda; Slade, Gary D.; Nackley, Andrea G.; Bhalang, Konakporn; Sigurdsson, Asgeir; Belfer, Inna; Goldman, David; Xu, Ke; Shabalina, Svetlana A.; Shagin, Dmitry; Max, Mitchell B.; Makarov, Sergei S.; Maixner, William.

In: Human Molecular Genetics, Vol. 14, No. 1, 01.01.2005, p. 135-143.

Research output: Contribution to journalArticle

Diatchenko, L, Slade, GD, Nackley, AG, Bhalang, K, Sigurdsson, A, Belfer, I, Goldman, D, Xu, K, Shabalina, SA, Shagin, D, Max, MB, Makarov, SS & Maixner, W 2005, 'Genetic basis for individual variations in pain perception and the development of a chronic pain condition', Human Molecular Genetics, vol. 14, no. 1, pp. 135-143. https://doi.org/10.1093/hmg/ddi013
Diatchenko, Luda ; Slade, Gary D. ; Nackley, Andrea G. ; Bhalang, Konakporn ; Sigurdsson, Asgeir ; Belfer, Inna ; Goldman, David ; Xu, Ke ; Shabalina, Svetlana A. ; Shagin, Dmitry ; Max, Mitchell B. ; Makarov, Sergei S. ; Maixner, William. / Genetic basis for individual variations in pain perception and the development of a chronic pain condition. In: Human Molecular Genetics. 2005 ; Vol. 14, No. 1. pp. 135-143.
@article{aaf915094ed54a4dbba785b857cc647d,
title = "Genetic basis for individual variations in pain perception and the development of a chronic pain condition",
abstract = "Pain sensitivity varies substantially among humans. A significant part of the human population develops chronic pain conditions that are characterized by heightened pain sensitivity. We identified three genetic variants (haplotypes) of the gene encoding catecholamine-O-methyltransferase (COMT) that we designated as low pain sensitivity (LPS), average pain sensitivity (APS) and high pain sensitivity (HPS). We show that these haplotypes encompass 96{\%} of the human population, and five combinations of these haplotypes are strongly associated (P = 0.0004) with variation in the sensitivity to experimental pain. The presence of even a single LPS haplotype diminishes, by as much as 2.3 times, the risk of developing myogenous temporomandibular joint disorder (TMD), a common musculoskeletal pain condition. The LPS haplotype produces much higher levels of COMT enzymatic activity when compared with the APS or HPS haplotypes. Inhibition of COMT in the rat results in a profound increase in pain sensitivity. Thus, COMT activity substantially influences pain sensitivity, and the three major haplotypes determine COMT activity in humans that inversely correlates with pain sensitivity and the risk of developing TMD.",
author = "Luda Diatchenko and Slade, {Gary D.} and Nackley, {Andrea G.} and Konakporn Bhalang and Asgeir Sigurdsson and Inna Belfer and David Goldman and Ke Xu and Shabalina, {Svetlana A.} and Dmitry Shagin and Max, {Mitchell B.} and Makarov, {Sergei S.} and William Maixner",
year = "2005",
month = "1",
day = "1",
doi = "10.1093/hmg/ddi013",
language = "English (US)",
volume = "14",
pages = "135--143",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Genetic basis for individual variations in pain perception and the development of a chronic pain condition

AU - Diatchenko, Luda

AU - Slade, Gary D.

AU - Nackley, Andrea G.

AU - Bhalang, Konakporn

AU - Sigurdsson, Asgeir

AU - Belfer, Inna

AU - Goldman, David

AU - Xu, Ke

AU - Shabalina, Svetlana A.

AU - Shagin, Dmitry

AU - Max, Mitchell B.

AU - Makarov, Sergei S.

AU - Maixner, William

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Pain sensitivity varies substantially among humans. A significant part of the human population develops chronic pain conditions that are characterized by heightened pain sensitivity. We identified three genetic variants (haplotypes) of the gene encoding catecholamine-O-methyltransferase (COMT) that we designated as low pain sensitivity (LPS), average pain sensitivity (APS) and high pain sensitivity (HPS). We show that these haplotypes encompass 96% of the human population, and five combinations of these haplotypes are strongly associated (P = 0.0004) with variation in the sensitivity to experimental pain. The presence of even a single LPS haplotype diminishes, by as much as 2.3 times, the risk of developing myogenous temporomandibular joint disorder (TMD), a common musculoskeletal pain condition. The LPS haplotype produces much higher levels of COMT enzymatic activity when compared with the APS or HPS haplotypes. Inhibition of COMT in the rat results in a profound increase in pain sensitivity. Thus, COMT activity substantially influences pain sensitivity, and the three major haplotypes determine COMT activity in humans that inversely correlates with pain sensitivity and the risk of developing TMD.

AB - Pain sensitivity varies substantially among humans. A significant part of the human population develops chronic pain conditions that are characterized by heightened pain sensitivity. We identified three genetic variants (haplotypes) of the gene encoding catecholamine-O-methyltransferase (COMT) that we designated as low pain sensitivity (LPS), average pain sensitivity (APS) and high pain sensitivity (HPS). We show that these haplotypes encompass 96% of the human population, and five combinations of these haplotypes are strongly associated (P = 0.0004) with variation in the sensitivity to experimental pain. The presence of even a single LPS haplotype diminishes, by as much as 2.3 times, the risk of developing myogenous temporomandibular joint disorder (TMD), a common musculoskeletal pain condition. The LPS haplotype produces much higher levels of COMT enzymatic activity when compared with the APS or HPS haplotypes. Inhibition of COMT in the rat results in a profound increase in pain sensitivity. Thus, COMT activity substantially influences pain sensitivity, and the three major haplotypes determine COMT activity in humans that inversely correlates with pain sensitivity and the risk of developing TMD.

UR - http://www.scopus.com/inward/record.url?scp=19944427292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944427292&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddi013

DO - 10.1093/hmg/ddi013

M3 - Article

VL - 14

SP - 135

EP - 143

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 1

ER -